Search Orphan Drug Designations and Approvals
-
Generic Name: | 4-benzyl-2-(a-naphtyl)-1,2,4-thiadiazolidine-3,5-dione |
---|---|
Date Designated: | 10/13/2009 |
Orphan Designation: | Treatment of progressive supranuclear palsy |
Orphan Designation Status: | Designated/Designation Withdrawn or Revoked |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
NOSCIRA, S.A. Avda. de la Industria, 52 Madrid Spain The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-